Exosomes derived from OM‐MSCs had the capacity to reduce the levels of proinflammatory factors (IL‐6, IL‐1β, and TNF‐α) and promote apoptosis in hemin‐induced HT22 cells. This evidence concerns the gene IL6 and ocular melanoma.